Multiple system atrophy (MSA) is a progressive neurodegenerative disease presenting with combinations of autonomic dysfunction, parkinsonism, cerebellar ataxia and/or pyramidal signs. Oligodendroglial cytoplasmic inclusions (GCIs) rich in α-synuclein (α-syn) constitute the disease hallmark, accompanied by neuronal loss and activation of glial cells which indicate neuroinflammation. Recent studies demonstrate that α-syn may be released from degenerating neurons to mediate formation of abnormal inclusion bodies and to induce neuroinflammation which, interestingly, might also favor the formation of intracellular α-syn aggregates as a consequence of cytokine release and the shift to a pro-inflammatory environment. Here, we critically review the...
α-Synucleinopathies comprise a group of neurodegenerative disorders that share α-synuclein (αS) accu...
Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease arising from the mi...
Multiple system atrophy (MSA) is a sporadic neurodegenerative disease manifested clinically by progr...
Abstract Multiple system atrophy (MSA) is a unique and fatal α-synucleinopathy associated with oligo...
International audienceAbstract Synucleinopathies encompass several neurodegenerative diseases, which...
Multiple system atrophy (MSA) closely resembles Parkinson's disease clinically but with a range of a...
doi: 10.3389/fncel.2015.00437 Multiple system atrophy (MSA) is a progressive neurodegenerative disea...
Multiple system atrophy (MSA) is a rapidly progressing fatal synucleinopathy of the aging population...
Summary: Glial cytoplasmic inclusions (GCIs), commonly observed as α-synuclein (α-syn)-positive aggr...
Selective loss of neurons, abnormal protein deposition and neuroinflammation are the common patholog...
Synucleinopathies are neurodegenerative disorders characterized by intracellular protein aggregates,...
Neuroinflammation and oligodendroglial cytoplasmic alpha-synuclein (alpha-syn) inclusions (GCIs) are...
Multiple system atrophy (MSA) exhibits widespread astrogliosis together with α-synuclein (α-syn) gli...
Multiple system atrophy (MSA) exhibits widespread astrogliosis together with α-synuclein (α-syn) gli...
Glial cytoplasmic inclusions (GCIs) containing aggregated and hyperphosphorylated α-synuclein are th...
α-Synucleinopathies comprise a group of neurodegenerative disorders that share α-synuclein (αS) accu...
Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease arising from the mi...
Multiple system atrophy (MSA) is a sporadic neurodegenerative disease manifested clinically by progr...
Abstract Multiple system atrophy (MSA) is a unique and fatal α-synucleinopathy associated with oligo...
International audienceAbstract Synucleinopathies encompass several neurodegenerative diseases, which...
Multiple system atrophy (MSA) closely resembles Parkinson's disease clinically but with a range of a...
doi: 10.3389/fncel.2015.00437 Multiple system atrophy (MSA) is a progressive neurodegenerative disea...
Multiple system atrophy (MSA) is a rapidly progressing fatal synucleinopathy of the aging population...
Summary: Glial cytoplasmic inclusions (GCIs), commonly observed as α-synuclein (α-syn)-positive aggr...
Selective loss of neurons, abnormal protein deposition and neuroinflammation are the common patholog...
Synucleinopathies are neurodegenerative disorders characterized by intracellular protein aggregates,...
Neuroinflammation and oligodendroglial cytoplasmic alpha-synuclein (alpha-syn) inclusions (GCIs) are...
Multiple system atrophy (MSA) exhibits widespread astrogliosis together with α-synuclein (α-syn) gli...
Multiple system atrophy (MSA) exhibits widespread astrogliosis together with α-synuclein (α-syn) gli...
Glial cytoplasmic inclusions (GCIs) containing aggregated and hyperphosphorylated α-synuclein are th...
α-Synucleinopathies comprise a group of neurodegenerative disorders that share α-synuclein (αS) accu...
Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease arising from the mi...
Multiple system atrophy (MSA) is a sporadic neurodegenerative disease manifested clinically by progr...